法国转诊中心膝关节或髋关节假体关节感染患者两阶段翻修的经济学研究数据表：再植入时使用创新干预降低重复感染风险

数据集获取（Figshare）

• 源站标题：Data_Sheet_1_Economic Study of 2-Stage Exchange in Patients With Knee or Hip Prosthetic Joint Infection Managed in a Referral Center in France: Time to Use Innovative(s) Intervention(s) at the Time of Reimplantation to Reduce the Risk of Superinfection.docx
• DOI：10.3389/fmed.2021.552669.s001
• 发布日期：2021-05-10
• 文件数：1 个
• 文件总体积：27.53 KB
• 源站页面：https://frontiersin.figshare.com/articles/dataset/Data_Sheet_1_Economic_Study_of_2-Stage_Exchange_in_Patients_With_Knee_or_Hip_Prosthetic_Joint_Infection_Managed_in_a_Referral_Center_in_France_Time_to_Use_Innovative_s_Intervention_s_at_the_Time_of_Reimplantation_to_Reduce_the_Risk_of_Super/14566209

命令行下载

curl -L -o "Data_Sheet_1_Economic Study of 2-Stage Exchange in Patients With Knee or Hip Prosthetic Joint Infection Managed in a Referral Center in France: Time t.docx" "https://ndownloader.figshare.com/files/27950655"

文件清单

• Data_Sheet_1_Economic Study of 2-Stage Exchange in Patients With Knee or Hip Prosthetic Joint Infection Managed in a Referral Center in France: Time t.docx（27.53 KB）

文件总体积 27.53 KB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

Objective: Chronic prosthetic joint infections (PJI) are serious complications in arthroplasty leading to prosthesis exchange and potential significant costs for health systems, especially if a subsequent new infection occurs. This study assessed the cost of chronic PJI managed with 2-stage exchange at the Lyon University Hospital, CRIOAc Lyon reference center, France. A threshold analysis was then undertaken to determine the reimbursement tariff of a hypothetical preventive device usable at the time of reimplantation, which possibly enables health insurance to save money according to the risk reduction of subsequent new infection. This analysis was also performed for a potential innovative device already available on the market, a dual antibiotic loaded bone cement used to fix cemented prosthesis that releases high concentrations of gentamicin and vancomycin locally (G+V cement).
Method: Patients >18 years, admitted for a hip or knee chronic PJI managed with 2-stage exchange, between January 1, 2013, and December 31, 2015, were retrospectively identified. Following, resource consumption in relation to inpatient hospital stay, hospitalization at home, rehabilitation care, outpatient antibiotic treatments, imaging, laboratory analysis, and consultations were identified and collected from patient records and taken into account in the evaluation. Costs were assessed from the French health insurance perspective over the 2 years following prosthesis reimplantation.
Results: The study included 116 patients (median age 67 y; 47% hip prosthesis). Mean cost of chronic PJI was estimated over the 2 years following prosthesis reimplantation at €21,324 for all patients, and at €51,697 and €15,745 for patients with (n = 18) and without (n = 98) a subsequent new infection after reimplantation, respectively. According to the threshold analysis the reimbursement tariff (i) should not exceed €2,820 for a device which can reduce the risk of a new infection by 50% and (ii) was between €2,988 and €3,984 if the G + V cement can reduce the risk of a new infection by 80% (this reduction risk is speculative and has to be confirmed by clinical trials).
Conclusion: This study revealed tha

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.3389/fmed.2021.552669.s001（source: https://frontiersin.figshare.com/articles/dataset/Data_Sheet_1_Economic_Study_of_2-Stage_Exchange_in_Patients_With_Knee_or_Hip_Prosthetic_Joint_Infection_Managed_in_a_Referral_Center_in_France_Time_to_Use_Innovative_s_Intervention_s_at_the_Time_of_Reimplantation_to_Reduce_the_Risk_of_Super/14566209）。